Diena Abdelmaged

Diena Abdelmaged practices at St. Joseph Hospital in Nashua, New Hampshire, part of Covenant Health.

Diena Abdelmaged's NPI, 1598226391, was assigned on March 26, 2019. Diena Abdelmaged holds New Hampshire license 23988.

Diena Abdelmaged's primary practice is St. Joseph Hospital, at 172 Kinsley St, Nashua, NH 03060 in Hillsborough County. The practice phone is (603) 882-3000.

Diena Abdelmaged's primary practice is St. Joseph Hospital in Nashua, New Hampshire, part of Covenant Health. Diena Abdelmaged is also affiliated with MedStar St. Mary's Hospital. The medical group on file is NES Health. Dmand AI also links Diena Abdelmaged to 1 more hospital, 3 medical groups, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Diena Abdelmaged practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Diena Abdelmaged's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Diena Abdelmaged is licensed in New Hampshire.

CMS data shows 930 Medicare services from Diena Abdelmaged across 5 procedure codes in 2024, for 322 Medicare patients. Medicare paid $65,470 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 322 Medicare patients who saw Diena Abdelmaged in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Diena Abdelmaged's median patient age at 74, with 59% women.

In 2024, Diena Abdelmaged wrote 397 Medicare Part D claims for 158 patients. 87% of them were for generic drugs. CMS names the drug for 154 of them, across 7 drugs with 11 or more claims each, at $645 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Diena Abdelmaged for performance year 2024, reported as part of a group. Diena Abdelmaged accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Diena Abdelmaged from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $13.